Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Bacil Pharma Ltd.
Swot
Bacil Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Bacil Pharma Ltd. has 9 Strengths, 9 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(9)
Weakness
(9)
Opportunity
(0)
Threats
(0)
Others
(4)
Consistent Highest Return Stocks over Five Years
Relative Outperformance versus Industry over 1 Year
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Overbought by Money Flow Index (MFI)
Turnaround companies- loss to profit QoQ
Companies with Low Debt
Companies with Zero Promoter Pledge
Highest Recovery from 52 Week Low
Promoter decreasing their shareholding
PE higher than Industry PE
Promoter holding decreased by more than -2% QoQ
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low Piotroski Score : Companies with weak financials
Top Losers
Declining profitability: Falling ROCE
Stocks Underperforming their Industry Price Change in the Quarter
Bullish or Bearish Candlestick Strength - Indices
Significant Change in Promoter Shareholding - Latest Quarter
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
High PE with Negative ROE
